Showing results (451-460 of 612) with videos related to
Sort By:
Pageof 62
Multiple Sclerosis Journal - Experimental, Translational and Clinical|September 13, 2026
Predictors of high- versus low-intensity first-line multiple sclerosis treatmentsAmanda V Gusovsky Chevalier, Kyle Murray, Anna Lin, et al.Multiple Sclerosis Journal - Experimental, Translational and Clinical|August 29, 2025
Diffusion tensor imaging in the SPRINT-MS clinical trial: Advancing trial methodologyKen Sakaie, Mengke Du, Nancy Obuchowski, et al.Multiple Sclerosis Journal - Experimental, Translational and Clinical|January 20, 2018
A double-blind, placebo-controlled, single ascending-dose study of remyelinating antibody rHIgM22 in people with multiple sclerosisAndrew Eisen, Benjamin M Greenberg, James D Bowen, et al.Multiple Sclerosis Journal - Experimental, Translational and Clinical|January 20, 2018
Improved cognitive performance and event-related potential changes following working memory training in patients with multiple sclerosisThomas J Covey, Janet L Shucard, Ralph Hb Benedict, et al.Multiple Sclerosis Journal - Experimental, Translational and Clinical|January 27, 2018
Diagnosis and treatment of latent tuberculosis in patients with multiple sclerosis, expert consensus. On behalf of the Colombian Association of Neurology, Committee of Multiple SclerosisCarlos Navas, Carlos A Torres-Duque, Joe Munoz-Ceron, et al.Multiple Sclerosis Journal - Experimental, Translational and Clinical|March 3, 2018
Risk factors for fingolimod-induced lymphopenia in multiple sclerosisRyohei Ohtani, Masahiro Mori, Tomohiko Uchida, et al.Multiple Sclerosis Journal - Experimental, Translational and Clinical|February 27, 2018
A randomized study to evaluate the effect of exercise on fatigue in people with relapsing-remitting multiple sclerosis treated with fingolimodM Mäurer, K Schuh, S Seibert, et al.Multiple Sclerosis Journal - Experimental, Translational and Clinical|October 5, 2017
Testing patient-reported outcome measurement equivalence in multinational clinical trials: An exemplar using the 12-item Multiple Sclerosis Walking ScaleHussein Dib, Yusuf Tamam, Murat Terzi, et al.Multiple Sclerosis Journal - Experimental, Translational and Clinical|October 6, 2017
Cognitive and neuropsychiatric disorders among MS patients from Latin AmericaSandra Vanotti, Fernando J CaceresMultiple Sclerosis Journal - Experimental, Translational and Clinical|October 6, 2017
Application of the McDonald criteria in Latin AmericaLiliana PatruccoPageof 62